Incidence of infections after therapy completion in children with acute lymphoblastic leukemia or acute myeloid leukemia: a systematic review of the literature

References

• Pui CH, Evans WE. Treatment of acute lymphoblastic leukemia. N Engl J Med. 2006;354:166–178.
   PubMed Web of Science ®Google Scholar
• Creutzig U, Zimmermann M, Lehrnbecher T, et al. Less toxicity by optimizing chemotherapy, but not by addition of granulocyte colony-stimulating factor in children and adolescents with acute myeloid leukemia: results of AML-BFM 98. JCO. 2006;24:4499–4506.
   PubMed Web of Science ®Google Scholar
• Ravindranath Y, Chang M, Steuber CP, et al. Pediatric Oncology Group (POG) studies of acute myeloid leukemia (AML): a review of four consecutive childhood AML trials conducted between 1981 and 2000. Leukemia. 2005;19:2101–2116.
   PubMed Web of Science ®Google Scholar
• Stevens RF, Hann IM, Wheatley K, et al. Marked improvements in outcome with chemotherapy alone in paediatric acute myeloid leukemia: results of the United Kingdom Medical Research Council's 10th AML trial. MRC Childhood Leukaemia Working Party. Br J Haematol. 1998;101:130–140.
   PubMed Web of Science ®Google Scholar
• Kurt BA, Nolan VG, Ness KK, et al. Hospitalization rates among survivors of childhood cancer in the Childhood Cancer Survivor Study cohort. Pediatr Blood Cancer. 2012;59:126–132.
   PubMed Web of Science ®Google Scholar
• Perkins JL, Chen Y, Harris A, et al. Infections among long-term survivors of childhood and adolescent cancer: a report from the Childhood Cancer Survivor Study. Cancer. 2014;120:2514–2521.
   PubMed Web of Science ®Google Scholar
• Suzuki M. Lymphocyte functions of child patients with ALL (acute lymphoblastic leukemia) in remission. Jpn J Clin Oncol. 1984;14:31–40.
   PubMed Web of Science ®Google Scholar
• Kristinsson VH, Kristinsson JR, Jonmundsson GK, et al. Immunoglobulin class and subclass concentrations after treatment of childhood leukemia. Pediatr Hematol Oncol. 2001;18:167–172.
   PubMed Web of Science ®Google Scholar
• van Tilburg CM, Bierings MB, Berbers GA, et al. Impact of treatment reduction for childhood acute lymphoblastic leukemia on serum immunoglobulins and antibodies against vaccine-preventable diseases. Pediatr Blood Cancer. 2012;58:701–707.
   PubMed Web of Science ®Google Scholar
• Reinhardt D, Houliara K, Pekrun A, et al. Impact of conventional chemotherapy on levels of antibodies against vaccine-preventable diseases in children treated for cancer. Scand J Infect Dis. 2003;35:851–857.
   PubMed Web of Science ®Google Scholar
• Smitherman AB, Wilkins TM, Blatt J, et al. Early Posttherapy Hospitalizations Among Survivors of Childhood Leukemia and Lymphoma. J Pediatr Hematol Oncol. 2016;38:423–428.
   PubMed Web of Science ®Google Scholar
• Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics. 1977;33:159–174.
   PubMed Web of Science ®Google Scholar
• Sterne JA, Hernan MA, Reeves BC, et al. ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions. BMJ. 2016;355:i4919
   PubMed Web of Science ®Google Scholar
• Moher D, Liberati A, Tetzlaff J, et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med. 2009;151:264–269.
   PubMed Web of Science ®Google Scholar
• Arico M, Maggiore G, Silini E, et al. Hepatitis C virus infection in children treated for acute lymphoblastic leukemia. Blood. 1994;84:2919–2922.
   PubMed Web of Science ®Google Scholar
• Arora B, Joshi YK, Salhan RN, et al. Transfusion-associated hepatitis in children with hematologic malignancies in Northern India. Med Pediatr Oncol. 2003;41:166–168.
   PubMedGoogle Scholar
• Arpaci T, Kilicarslan Toruner E. Assessment of problems and symptoms in survivors of childhood acute lymphoblastic leukaemia. Eur J Cancer Care. 2016;25:1034–1043.
   PubMed Web of Science ®Google Scholar
• Barker JN, Hough RE, van Burik JAH, et al. Serious infections after unrelated donor transplantation in 136 children: Impact of stem cell source. Biol Blood Marrow Transplant. 2005;11:362–370.
   PubMed Web of Science ®Google Scholar
• Castellino S, Lensing S, Riely C, et al. The epidemiology of chronic hepatitis C infection in survivors of childhood cancer: an update of the St Jude Children's Research Hospital hepatitis C seropositive cohort. Blood. 2004;103:2460–2466.
   PubMed Web of Science ®Google Scholar
• Cavazzana-Calvo M, Bordigoni P, Michel G, et al. A phase II trial of partially incompatible bone marrow transplantation for high-risk acute lymphoblastic leukaemia in children: prevention of graft rejection with anti-LFA-1 and anti-CD2 antibodies. Br J Haematol. 1996;93:131–138.
   PubMed Web of Science ®Google Scholar
• Cerveri I, Zoia MC, Fulgoni P, et al. Late pulmonary sequelae after childhood bone marrow transplantation. Thorax. 1999;54:131–135.
   PubMed Web of Science ®Google Scholar
• Dell'Orto M, Rovelli A, Barzaghi A, et al. Febrile complications in the first 100 days after bone marrow transplantation in children: a single center's experience. Pediatr Hematol Oncol. 1997;14:335–347.
   PubMed Web of Science ®Google Scholar
• Esposito S, Cecinati V, Scicchitano B, et al. Impact of influenza-like illness and effectiveness of influenza vaccination in oncohematological children who have completed cancer therapy. Vaccine. 2010;28:1558–1565.
   PubMed Web of Science ®Google Scholar
• Ferry C, Gemayel G, Rocha V, et al. Long-term outcomes after allogeneic stem cell transplantation for children with hematological malignancies. Bone Marrow Transplant. 2007;40:219–224.
   PubMed Web of Science ®Google Scholar
• Gordon BG, Warkentin PI, Strandjord SE, et al. Allogeneic bone marrow transplantation for children with acute leukemia: long-term follow-up of patients prepared with high-dose cytosine arabinoside and fractionated total body irradiation. Bone Marrow Transplant. 1997;20:5–10.
   PubMed Web of Science ®Google Scholar
• Koskenvuo M, Rahiala J, Sadeghi M, et al. Viremic co-infections in children with allogeneic haematopoietic stem cell transplantation are predominated by human polyomaviruses. Infect Dis. 2017;49:35–41.
   PubMed Web of Science ®Google Scholar
• Leung W, Hudson MM, Strickland DK, et al. Late effects of treatment in survivors of childhood acute myeloid leukemia. J Clin Oncol. 2000;18:3273–3279.
   PubMed Web of Science ®Google Scholar
• Locasciulli A, Vergani GM, Uderzo C, et al. Chronic liver disease in children with leukemia in long-term remission. Cancer. 1983;52:1080–1087.
   PubMed Web of Science ®Google Scholar
• Locasciulli A, Alberti A, Rossetti F, et al. Acute and chronic hepatitis in childhood leukemia: a multicentric study from the Italian Pediatric Cooperative Group for Therapy of Acute Leukemia (AIL-AIEOP). Med Pediatr Oncol. 1985;13:203–206.
   PubMedGoogle Scholar
• Locasciulli A, Gornati G, Tagger A, et al. Hepatitis C virus infection and chronic liver disease in children with leukemia in long-term remission. Blood. 1991;78:1619–1622.
   PubMed Web of Science ®Google Scholar
• Locasciulli A, Testa M, Pontisso P, et al. Prevalence and natural history of hepatitis C infection in patients cured of childhood leukemia. Blood. 1997;90:4628–4633.
   PubMed Web of Science ®Google Scholar
• Matsuzaki A, Ishii E, Nagatoshi Y, et al. Long-term outcome of treatment with protocols AL841, AL851, and ALHR88 in children with acute lymphoblastic leukemia: results obtained by the Kyushu-Yamaguchi Children's Cancer Study Group. Int J Hematol. 2001;73:369–377.
   PubMed Web of Science ®Google Scholar
• Michel M, Vermylen C, Sokal E, et al. Bone marrow transplantation for poor prognosis ALL in children. Relapse rate, infections and immunological recovery. Acta Clin Belg. 1988;43:254–260.
   PubMed Web of Science ®Google Scholar
• Ochs JJ, Rivera G, Aur RJ, et al. Central nervous system morbidity following an initial isolated central nervous system relapse and its subsequent therapy in childhood acute lymphoblastic leukemia. JCO. 1985;3:622–626.
   PubMed Web of Science ®Google Scholar
• Olkinuora HA, Taskinen MH, Saarinen-Pihkala UM, et al. Multiple viral infections post-hematopoietic stem cell transplantation are linked to the appearance of chronic GVHD among pediatric recipients of allogeneic grafts. Pediatr Transplant. 2010;14:242–248.
   PubMed Web of Science ®Google Scholar
• Peters C, Schrappe M, von Stackelberg A, et al. Stem-cell transplantation in children with acute lymphoblastic leukemia: A prospective international multicenter trial comparing sibling donors with matched unrelated donors-the ALL-SCT-BFM-2003 trial. JCO. 2015;33:1265–1274.
   PubMed Web of Science ®Google Scholar
• Remberger M, Ringden O. Similar outcome after unrelated allogeneic peripheral blood stem cell transplantation compared with bone marrow in children and adolescents. Transplantation. 2007;84:551–554.
   PubMed Web of Science ®Google Scholar
• Rossetti F, Zancan L, Bonato MG, et al. Delta virus and childhood leukemia. Pediatr Hematol Oncol. 1991;8:23–32.
   PubMed Web of Science ®Google Scholar
• Skou AS, Glosli H, Jahnukainen K, et al. Renal, gastrointestinal, and hepatic late effects in survivors of childhood acute myeloid leukemia treated with chemotherapy only-a NOPHO-AML study. Pediatr Blood Cancer. 2014;61:1638–1643.
   PubMedGoogle Scholar
• Tsurusawa M, Shimomura Y, Asami K, et al. Long-term results of the Japanese childhood cancer and leukemia study group studies 811, 841, 874 and 911 on childhood acute lymphoblastic leukemia. Leukemia. 2010;24:335–344.
   PubMed Web of Science ®Google Scholar
• Yi ES, Kim YJ. Cytomegalovirus infection according to cell source after hematopoietic cell transplantation in pediatric patients. Yonsei Med J. 2012;53:393–400.
   PubMed Web of Science ®Google Scholar
• Zintl F, Farber I, Hermann J, et al. CMV infections in bone marrow transplanted patients–evaluation of prophylaxis with Cytotect (CMV hyperimmuneglobulin). Folia Haematol Int Mag Klin Morphol Blutforsch. 1989;116:557–564.
   PubMedGoogle Scholar
• Gratwohl A, Brand R, Frassoni F, et al. Cause of death after allogeneic haematopoietic stem cell transplantation (HSCT) in early leukaemias: an EBMT analysis of lethal infectious complications and changes over calendar time. Bone Marrow Transplant. 2005;36:757–769.
   PubMed Web of Science ®Google Scholar
• Lorenzi MF, Xie L, Rogers PC, et al. Hospital-related morbidity among childhood cancer survivors in British Columbia, Canada: report of the childhood, adolescent, young adult cancer survivors (CAYACS) program. Int J Cancer. 2011;128:1624–1631.
   PubMed Web of Science ®Google Scholar
• Haining NW, Duncan CN, El-Haddad A, et al. Principles of bone marrow and stem cell transplantation. In: Orkin SH, Nathan DG, Ginsburg D, et al. editors. Nathan and Oski's hematology of infancy and childhood. Vol. 1. 8th ed. United Kingdom: Elsevier Health Sciences; 2015. p. 254–290.
   Google Scholar